NYSE - Nasdaq Real Time Price USD

The Gabelli Healthcare & Wellness Trust (GRX)

9.64 +0.15 (+1.58%)
As of 10:58 AM EDT. Market Open.
Loading Chart for GRX
DELL
  • Previous Close 9.49
  • Open 9.52
  • Bid 9.63 x 800
  • Ask 9.64 x 1000
  • Day's Range 9.58 - 9.64
  • 52 Week Range 7.73 - 10.40
  • Volume 6,622
  • Avg. Volume 33,643
  • Market Cap (intraday) 152.314M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 37.08
  • EPS (TTM) 0.26
  • Earnings Date --
  • Forward Dividend & Yield 0.60 (7.43%)
  • Ex-Dividend Date Sep 14, 2023
  • 1y Target Est --

The Gabelli Healthcare and Wellness Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC. It invests in the public equity markets across the globe. The fund seeks to invest in stocks of companies primarily operating in the healthcare and wellness sector. It invests in stocks of companies across all market capitalizations. The fund benchmarks the performance of its portfolio against the S&P 500 Index, S&P 500 Consumer Staples Index, and S&P 500 Health Care Index. The Gabelli Healthcare & Wellness Trust was formed on February 20, 2007 and is domiciled in the United States.

www.gabelli.com/Template/fundinfo.cfm?tid=MTNlMzU=&bid=ZDg2&mid=NWRiNDg=&num=MzM0MGQ=&kid=NTA4NzQ=&pid=obj&rid=811-=edoc_dnuf

--

Full Time Employees

--

Fiscal Year Ends

Recent News: GRX

Performance Overview: GRX

Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

GRX
4.88%
S&P 500
6.25%

1-Year Return

GRX
0.26%
S&P 500
22.61%

3-Year Return

GRX
9.79%
S&P 500
22.56%

5-Year Return

GRX
22.99%
S&P 500
74.28%

Compare To: GRX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: GRX

Valuation Measures

Annual
As of 4/22/2024
  • Market Cap

    149.95M

  • Enterprise Value

    --

  • Trailing P/E

    118.62

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    122.11

  • Price/Book (mrq)

    0.81

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    0.26

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Company Insights: GRX

People Also Watch